Clinical Characteristics of Diabetic Patients with COVID-19

Li G, Deng Q, Feng J, Li F, Xiong N, He Q.

Quarantine Due to the COVID-19 Pandemic From the Perspective of Pediatric Patients With Type 1 Diabetes: A Web-Based Survey

Passanisi S, Pecoraro M, Pira F, Alibrandi A, Donia V, Lonia P, Pajno GB, Salzano G, Lombardo F.

DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Smelcerovic A, Kocic G, Gajic M, Tomovic K, Djordjevic V, Stankovic-Djordjevic D, Anderluh M.

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

Valencia I, Peiró C, Lorenzo Ó, Sánchez-Ferrer CF, Eckel J, Romacho T.

Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study

Chang MC, Hwang JM, Jeon JH, Kwak SG, Park D, Moon JS.

The COVID-19 pandemic and diabetes mellitus

Papazafiropoulou AK, Antonopoulos S.

Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) receptor and the SARS-CoV-2 main protease

Sudeep HV, Gouthamchandra K, Shyamprasad K.

Caring for children and adolescents with type 1 diabetes mellitus: italian society for pediatric and adolescent diabetes (ISPED) Statements during COVID-19 pandemia

d'Annunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R, Minuto N, Piccolo G, Maghnie M.

Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?

Tittel SR, Rosenbauer J, Kamrath C, Ziegler J, Reschke F, Hammersen J, Mönkemöller K, Pappa A, Kapellen T, Holl RW; DPV Initiative.

A multistage combined approach to promote diabetic wound healing in COVID-19 era

Grande R, Fiori G, Russo G, Fioramonti P, Campagnol M, di Marzo L.

Diabetes and Covid-19: An interplay difficult to dissect

Napoli R.

New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K

Unsworth R, Wallace S, Oliver NS, Yeung S, Kshirsagar A, Naidu H, Kwong RMW, Kumar P, Logan KM.

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes

Alzaid F, Julla JB, Diedisheim M, Potier C, Potier L, Velho G, Gaborit B, Manivet P, Germain S, Vidal-Trecan T, Roussel R, Riveline JP, Dalmas E, Venteclef N, Gautier JF.

Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]

Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators.

Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis

Shang L, Shao M, Guo Q, Shi J, Zhao Y, Xiaokereti J, Tang B.

COVID-19 and diabetes: Covidiabetology

Kalra S, Mittal S.

Severe diabetic ketoacidosis and coronavirus disease 2019 (COVID-19) infection in a teenage patient with newly diagnosed diabetes

Rabizadeh S, Hajmiri M, Rajab A, Emadi Kouchak H, Nakhjavani M.

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

Paolo Fadini G, Luca Morieri M, Boscari F, Fioretto P, Maran A, Busetto L, Maria Bonora B, Selmin E, Arcidiacono G, Pinelli S, Farnia F, Falaguasta D, Russo L, Voltan G, Mazzocut S, Costantini G, Ghirardini F, Tresso S, Maria Cattelan A, Vianello A, Avogaro A, Vettor R.

Fast-track pathway for diabetic foot ulceration during COVID-19 crisis: a document from International Diabetic Foot Care Group and D-Foot International

Meloni M, Bouillet B, Ahluwalia R, Lüdemann C, Sánchez-Ríos JP, Iacopi E, Lazaro Martinez JL.

The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis

Fox T, Ruddiman K, Lo KB, Peterson E, DeJoy R 3rd, Salacup G, Pelayo J, Bhargav R, Gul F, Albano J, Azmaiparashvili Z, Anastasopoulou C, Patarroyo-Aponte G.

Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)

Panzuto F, Maccauro M, Campana D, Faggiano A, Massironi S, Pusceddu S, Spada F, Ferone D, Modica R, Grana CM, Ferolla P, Rinzivillo M, Badalamenti G, Zatelli MC, Gelsomino F, De Carlo E, Bartolomei M, Brizzi MP, Cingarlini S, Versari A, Fanciulli G, Arvat E, Merola E, Cives M, Tafuto S, Baldari S, Falconi M.

Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortality

Tascioglu D, Yalta K, Yetkin E.

Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?

Pal R, Banerjee M.

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, Wareham NJ, Young B, Valabhji J.

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J.

Bridging the Needs of Adolescent Diabetes Care During Coronavirus Disease 2019: A Nurse-Led Telehealth Initiative

Lim ST, Yap F, Chin X.

Tackling Obesity During the COVID-19 Pandemic

Akirov A, Cahn A, Del Prato S, Home P, Van Gaal L, Chan J, Ning G, Raz I; Global CODHY Expert Forum.

Diabetes care during COVID 19: Experience in telemedicine from a developing country

García-Villasante E, Baca-Carrasco V, Gutierrez-Ortiz C, Pinedo-Torres I.

A proposed ABCD scoring system for patient's self assessment and at emergency department with symptoms of COVID-19

Salunke AA, Pathak SK, Dhanwate A, Warikoo V, Nandy K, Mendhe H, Kottakota V, Shinde RM, Patil SA, Petiwala T, Pandya S.

A Diabetes and COVID-19 Dilemma: Balancing Parents' Health & Children's Education

Mehta PB, Rushakoff RJ.

The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea

Kim MK, Jeon JH, Kim SW, Moon JS, Cho NH, Han E, You JH, Lee JY, Hyun M, Park JS, Kwon YS, Choi YK, Kwon KT, Lee SY, Jeon EJ, Kim JW, Hong HL, Kwon HH, Jung CY, Lee YY, Ha E, Chung SM, Hur J, Ahn JH, Kim NY, Kim SW, Chang HH, Lee YH, Lee J, Park KG, Kim HA, Lee JH.

Children's Anxiety and Physical Activity during COVID-19 in Relation to Prenatal Exposure to Gestational Diabetes

Alves J, Yunker AG, DeFendis A, Xiang AH, Page KA.

COVID-19, ketoacidosis, and new-onset Diabetes: might we envisage any cause-effect relationships among them?

Gentile S, Strollo F, Mambro A, Ceriello A.

Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes

Dhurandhar NV, Akheruzzaman M, Hegde V.

Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors

Taneera J, El-Huneidi W, Hamad M, Mohammed AK, Elaraby E, Hachim MY.

Hospital Diabetes Meeting 2020

Umpierrez G, Rushakoff R, Seley JJ, Zhang JY, Shang T, Han J, Spanakis EK, Alexanian S, Drincic A, Kulasa K, Mendez CE, Tanton D, Wallia A, Zilbermint M, Klonoff DC.

Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series

Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, Latrofa F.

A Territory-wide Study on the Impact of COVID-19 on Diabetes-Related Acute Care

Lui DTW, Lee CH, Chow WS, Fong CHY, Woo YC, Lam KSL, Tan KCB.

Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review

Lisco G, De Tullio A, Giagulli VA, Guastamacchia E, De Pergola G, Triggiani V.

Managing Hyperglycemia in the COVID-19 Inflammatory Storm

Gianchandani R, Esfandiari NH, Ang L, Iyengar J, Knotts S, Choksi P, Pop-Busui R.

Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?

Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes*; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes.

COVID-19 and steroid therapy: Impact on diabetes

Mittal S, Madan K, Mohan A.

Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy

Ciardullo S, Zerbini F, Perra S, Muraca E, Cannistraci R, Lauriola M, Grosso P, Lattuada G, Ippoliti G, Mortara A, Manzoni G, Perseghin G.

Postoperative vocal fold dysfunction in covid-19 era: are we still in time for a recovery?

Bonati E, Bignami EG, Del Rio P.

Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19

Carpagnano GE, Di Lecce V, Quaranta VN, Zito A, Buonamico E, Capozza E, Palumbo A, Di Gioia G, Valerio VN, Resta O.

Prediction of new active cases of coronavirus disease (COVID-19) pandemic using multiple linear regression model

Rath S, Tripathy A, Tripathy AR.

Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection

Hariyanto TI, Kurniawan A.

Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature

Reddy PK, Kuchay MS, Mehta Y, Mishra SK.

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a r

Akram J, Azhar S, Shahzad M, Latif W, Khan KS.

Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program-Results from a Comparative Effectiveness Trial

Palmer KNB, Garr Barry VE, Marrero DG, McKinney BM, Graves AN, Winters CK, Hannon TS.

Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience

Reutrakul S, Genco M, Salinas H, Sargis RM, Paul C, Eisenberg Y, Fang J, Caskey RN, Henkle S, Fatoorehchi S, Osta A, Srivastava P, Johnson A, Messmer SE, Barnes M, Pratuangtham S, Layden BT.

Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019

Agarwal S, Schechter C, Southern W, Crandall JP, Tomer Y.

Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection

Vamvini M, Lioutas VA, Middelbeek RJW.

The COVID-19 Outbreak Negatively Affects the Delivery of Care for Patients With Diabetic Foot Ulcers

Liu C, You J, Zhu W, Chen Y, Li S, Zhu Y, Ji S, Wang Y, Li H, Li L, Fan S.

ACE polymorphism and COVID-19 outcome

Delanghe JR, Speeckaert MM, De Buyzere ML.

The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study

Dalan R, Ang LW, Tan WYT, Fong SW, Tay WC, Chan YH, Renia L, Ng LFP, Lye DC, Chew DEK, Young BE.

METFORMIN USE IS ASSOCIATED WITH REDUCED MORTALITY IN A DIVERSE POPULATION WITH COVID-19 AND DIABETES

Crouse A, Grimes T, Li P, Might M, Ovalle F, Shalev A.

A Case of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in a Patient With COVID-19

Rafique S, Ahmed FW.

Diabetes and COVID-19 risk: a miRNA perspective

Mishra PK, Tandon R, Byrareddy SN.

Rapid Implementation of a Diabetes Telemedicine Clinic During the Coronavirus Disease 2019 Outbreak: Our Protocol, Experience, and Satisfaction Reports in Saudi Arabia

Al-Sofiani ME, Alyusuf EY, Alharthi S, Alguwaihes AM, Al-Khalifah R, Alfadda A.

COVID-19 and Diabetes: What Should We Expect?

Pedrosa MDS, Neves Nogueira F.

Diabetes in the Time of COVID-19: A Twitter-Based Sentiment Analysis

Cignarelli A, Sansone A, Caruso I, Perrini S, Natalicchio A, Laviola L, Jannini EA, Giorgino F.

COVID-19 and Diabetes: The Importance of Controlling RAGE

De Francesco EM, Vella V, Belfiore A.

Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan

Liu Z, Li J, Huang J, Guo L, Gao R, Luo K, Zeng G, Zhang T, Yi M, Huang Y, Chen J, Yang Y, Wu X.

COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus

Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, Garcimartín A, Sampedro-Nuñez MA, Dávalos A, Marazuela M.

Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review

Das S, Anu KR, Birangal SR, Nikam AN, Pandey A, Mutalik S, Joseph A.

Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration

Ayoub BM, Ramadan E, Ashoush N, Tadros MM, Hendy MS, Elmazar MM, Mousa SA.

Diabetic retinopathy screening and the COVID-19 pandemic in Brazil

Malerbi FK, Morales PHA, Regatieri CVS.

MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19

Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A, Madhavan MV, Nair N, Babalyan V, Hutchings NJ, Napoli N, Accili D, Binkley N, Landry DW, Giustina A.

Fighting infodemic: Need for robust health journalism in India

Sharma DC, Pathak A, Chaurasia RN, Joshi D, Singh RK, Mishra VN.

Tuberculosis in the era of COVID-19 in India

Jain VK, Iyengar KP, Samy DA, Vaishya R.

Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: A systematic review and meta-analysis

Salunke AA, Nandy K, Pathak SK, Shah J, Kamani M, Kottakota V, Thivari P, Pandey A, Patel K, Rathod P, Bhatt S, Dave P, Pandya S.

Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection

Hariyanto TI, Kurniawan A.

ARIMA modelling & forecasting of COVID-19 in top five affected countries

Sahai AK, Rath N, Sood V, Singh MP.

"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey"

Gangopadhyay KK, Sinha B, Ghosal S.

Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic"

Ferrario CM.

Is it the COVID-19 happy hypoxia syndrome or the COVID 19 infodemic syndrome?

Sahu D, Agrawal T.

Executive dysfunction in COVID-19 patients

Ardila A, Lahiri D.

Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges

Badgujar KC, Badgujar VC, Badgujar SB.

SARS-CoV-2-host dynamics: Increased risk of adverse outcomes of COVID-19 in obesity

Yadav R, Aggarwal S, Singh A.

Reverse quarantine and COVID-19

Raveendran AV, Jayadevan R.

Corrigendum to "Vitamin D concentrations and COVID-19 infection in UK Biobank" [Diabetes Metabol Syndr: Clin Res Rev 2020 14 (4) 561-5]

Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, Jani BD, Welsh P, Mair FS, Gray SR, O'Donnell CA, Gill JM, Sattar N, Pell JP.

Applications of industry 4.0 to overcome the COVID-19 operational challenges

Kumar MS, Raut DRD, Narwane DVS, Narkhede DBE.

Retraction of: No Deleterious Effect of Lockdown Due to COVID-19 Pandemic on Glycaemic Control, Measured by Glucose Monitoring, in Adults with Type 1 Diabetes. Beato-Vibora PI. Diabetes Technol Ther 2020; epub DOI: 10.1089/dia.2020.0184

Thyroid cancer in the Era of COVID-19

Smulever A, Abelleira E, Bueno F, Pitoia F.

COVID-19 Pneumonia: An Emerging Cause of Syndrome of Inappropriate Antidiuretic Hormone

Sheikh MM, Ahmad E, Jeelani HM, Riaz A, Muneeb A.

Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019

Zhang J, Kong W, Xia P, Xu Y, Li L, Li Q, Yang L, Wei Q, Wang H, Li H, Zheng J, Sun H, Xia W, Liu G, Zhong X, Qiu K, Li Y, Wang H, Wang Y, Song X, Liu H, Xiong S, Liu Y, Cui Z, Hu Y, Chen L, Pan A, Zeng T.

Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis

Riddle MC.

Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?

Soldo J, Heni M, Königsrainer A, Häring HU, Birkenfeld AL, Peter A.

Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19)

Al-Lami RA, Urban RJ, Volpi E, Algburi AMA, Baillargeon J.

Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic

Meek CL, Lindsay RS, Scott EM, Aiken CE, Myers J, Reynolds R, Simmons D, Yamamoto JM, McCance DR, Murphy HR.

Knowledge levels among elderly people with Diabetes Mellitus concerning COVID-19: an educational intervention via a teleservice

de Lima Filho BF, Bessa NPOS, Fernandes ACT, da Silva Patrício ÍF, de Oliveira Alves N, da Costa Cavalcanti FA.

Diabetic retinopathy screening in urban primary care setting with a handheld smartphone-based retinal camera

Queiroz MS, de Carvalho JX, Bortoto SF, de Matos MR, das Graças Dias Cavalcante C, Andrade EAS, Correa-Giannella ML, Malerbi FK.

[COVID-19 and fragility hip fracture. Joint recommendations of the Spanish Society of Osteoporotic Fractures and the Spanish Society of Geriatrics and Gerontology]

Caeiro-Rey JR, Ojeda-Thies C, Cassinello-Ogea C, Sáez-López MP, Etxebarría-Foronda Í, Pareja-Sierra T, Larrainzar-Garijo R, Figueroa-Rodríguez J, Freire Romero A, Sende-Munin N, Del Río-Pombo E, Carro-Méndez B, Mesa-Ramos M, González-Macías J, Tarazona-Santabalbina FJ.

Management changes for patients with endocrine-related cancers in the COVID-19 pandemic

Raghavan D, Tan AR, Story ES, Burgess EF, Musselwhite L, Kim ES, Clark PE.

COVID-19 and diabetes mellitus: how one pandemic worsens the other

Azar WS, Njeim R, Fares AH, Azar NS, Azar ST, El Sayed M, Eid AA.

Why diabetes must not be forgotten in the global fight against COVID-19

Boulton A.

Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring

Dover AR, Ritchie SA, McKnight JA, Strachan MWJ, Zammitt NN, Wake D, Forbes S, Stimson RH, Gibb FW.

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Rayman G, Lumb AN, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney HC, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.

Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia

David McIntyre H, Gibbons KS, C W Ma R, Hung Tam W, Sacks DA, Lowe J, Madsen LR, Catalano PM.

The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring

Mesa A, Viñals C, Pueyo I 1st, Roca D, Vidal M, Giménez M, Conget I.

Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection

Smati S, Moreau PM, Bourdiol A, Ploteau S, Hadjadj S, Cariou B.

Bilateral adrenal hemorrhage in Coronavirus disease 2019 patient: A case report

Frankel M, Feldman I, Levine M, Frank Y, Bogot NR, Benjaminov O, Kurd R, Breuer GS, Munter G.

Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era

Aljehani FA, Funke K, Hermayer KL.

Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign

Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A.

Androgenetic alopecia in COVID-19: Compared to what?

Nanes BA.

[The endocrine and metabolic link between COVID-19, diabetes and obesity]

Weis N, Thorsteinsson K, Martinussen C, Madsbad S.

Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity -diabetes?

Pontiroli AE, La Sala L, Chiumello D, Folli F.

Estradiol, progesterone, immunomodulation and COVID-19 outcomes

Mauvais-Jarvis F, Klein SL, Levin ER.

Prescription rates of cardiovascular and diabetes therapies prior to and during the COVID-19 lockdown in Germany‚Ä©

Kostev K, Kumar S, Konrad M, Bohlken J.

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Infections among Diabetics: a Retrospective and Multicenter Study in China

Yi H, Lu F, Jin X, Chen R, Liu B, Dong X, Xiong W, Yang D, Guo Y, Zhou M.

Heightened ACE Activity and Unfavorable Consequences in COVID-19 Diabetic Subjects

Sandooja R, Vura NVRK, Morocco M.

Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019

Hayden MR.

Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin

Mozafari N, Azadi S, Mehdi-Alamdarlou S, Ashrafi H, Azadi A.

Virtual Consultations: Considerations for the Role of Technology During the Covid-19 Pandemic for People With Type Two Diabetes-UK Perspective

Quinn LM, Davies MJ, Hadjiconstantinou M.

Delineating clinical characteristics and comorbidities among 206 COVID-19deceasedpatients in India: Emerging significance of renin angiotensin system derangement

Majeed J, Ajmera P, Goyal RK.

Hyperglycemia is a strong predictor of poor prognosis in COVID-19

Liu SP, Zhang Q, Wang W, Zhang M, Liu C, Xiao X, Liu Z, Hu WM, Jin P.

More Studies are Needed on the Link between Metformin and Decreased Mortality in Diabetic COVID-19 Patients

Fysekidis M, Cohen R, Al-Salameh A.

Diabetes and COVID-19: A systematic review on the current evidences

Abdi A, Jalilian M, Ahmadi Sarbarzeh P, Vlaisavljevic Z.

The COVID19 Pandemic - Perspectives from People Living with Diabetes

Kyle Jacques R, Renza S.

Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus

Jing Liang J, Liu J, Chen Y, Ye B, Li N, Wang X, Tang M, Shao J.

Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes

Fern√°ndez E, Cortazar A, Bellido V.

Recommendations and management of hyperglycaemia in pregnancy during COVID-19 pandemic in Italy

Torlone E, Angela Sculli M, Bonomo M, Di Benedetto A, Di Cianni G, Festa C, Formoso G, Lapolla A, Mannino D, Napoli A, Scavini M, Succurro E, Vitacolonna E, Sciacca L.

Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: a meta-analysis

Guo L, Shi Z, Zhang Y, Wang C, Cristina Do Vale Moreira N, Zuo H, Hussain A.

Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey

Pal R, Yadav U, Grover S, Saboo B, Verma A, Bhadada SK.

Perceived Risk, Behavior Changes and Health-related Outcomes During COVID-19 Pandemic: Findingsamong Adults with and without Diabetesin China

Yan AF, Sun X, Zheng J, Mi B, Zuo H, Ruan G, Hussain A, Wang Y, Shi Z.

A 65-Year-Old Woman with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day History of Dry Cough and Fever Who Presented with Acute Renal Failure Due to Infection with SARS-Cov-2

Sánchez Tinajero Á, González Cueto E, Martínez Orozco JA, Becerril Vargas E, Ruiz Santillán DP, Reséndiz Escobar H.

COVID-19 Pandemic-Related Practices and Policies Affecting the Continuity of Behavioral Health Care Among Children With Diabetes

Clary L, Wang C, Byrne ME, Monaghan M.

Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns

Koliaki C, Tentolouris A, Eleftheriadou I, Melidonis A, Dimitriadis G, Tentolouris N.

Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center

Wu D, Gao S.

Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus

Liu D, Lan L, Luo D, Zhao B, Wei G, He Y, Zhang R, Liu Y.

COVID-19 and Diabetes: International Diabetes Federation Perspectives

Hussain A, Jm Boulton A.

Management of diabetes in patients with COVID-19 - Authors' reply

Bornstein SR, Zimmet P, Rubino F, Ludwig B.

Management of diabetes in patients with COVID-19

Khalangot M.

Management of diabetes in patients with COVID-19

Li A, Harris S, Kariyawasam D, Patel DC, Thomas SM.

Management of diabetes in patients with COVID-19

Munshi MN, Sy SL.

Management of diabetes in patients with COVID-19

Mukherjee JJ, Gangopadhyay KK, Ray S.

Management of diabetes in patients with COVID-19

Lalau JD, Al-Salameh A.

Newly diagnosed diabetes mellitus, DKA and COVID-19: causality or coincidence? - A report of 3 cases

Suwanwongse K, Shabarek N.

Mechanism of higher risk for COVID-19 in diabetes: a mask to lift

Fang C, Huang Y, Guo H, Sun Y, Li H, Bian X, Guan H, Hu J.

Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies

Caruso P, Longo M, Signoriello S, Gicchino M, Maiorino MI, Bellastella G, Chiodini P, Giugliano D, Esposito K.

Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany

Kamrath C, Mönkemöller K, Biester T, Rohrer TR, Warncke K, Hammersen J, Holl RW.

Endocrine disrupting chemicals and COVID-19 relationships: a computational systems biology approach

Wu Q, Coumoul X, Grandjean P, Barouki R, Audouze K.

SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer

La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A, Calogero AE.

COVID-19 and Diabetes

Brunton SA, Williams N.

Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies

Longo M, Caruso P, Maiorino MI, Bellastella G, Giugliano D, Esposito K.

THYROTOXICOSIS IN PATIENTS WITH COVID-19: THE THYRCOV STUDY

Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G.

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, Jimenez Restrepo JL, Vendramini PH, Reis-de-Oliveira G, Bispo Dos Santos K, Toledo-Teixeira DA, Parise PL, Martini MC, Marques RE, Carmo HR, Borin A, Coimbra LD, Boldrini VO, Brunetti NS, Vieira AS, Mansour E, Ulaf RG, Bernardes AF, Nunes TA, Ribeiro LC, Palma AC, Agrela MV, Moretti ML, Sposito AC, Pereira FB, Velloso LA, Vinolo MAR, Damasio A, Proença-Mód

A metabolic handbook for the COVID-19 pandemic

Ayres JS.

Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks

Gujral UP, Johnson L, Nielsen J, Vellanki P, Haw JS, Davis GM, Weber MB, Pasquel FJ.

Issues for the management of people with diabetes and COVID-19 in ICU

Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD).

A 46-Year-Old Woman Who Presented with Diabetic Ketoacidosis and COVID-19 Pneumonia with Multiple Pulmonary Thromboemboli: A Case Report

Haider MB, Abbas F, Hafeez W.

COVID-19 outbreak and pediatric diabetes: perceptions of health care professionals worldwide

Elbarbary NS, Dos Santos TJ, de Beaufort C, Agwu JC, Calliari LE, Scaramuzza AE.

SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19

Mateu-Salat M, Urgell E, Chico A.

The informative experience of endocrine residents with COVID-19

Di Stefano M, Federici S, Giovanelli L, Nadiani B, Nicoli F, Trevisan M.

COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d'Andrologie de langue Française SALF)

Hamdi S, Bendayan M, Huyghe E, Soufir JC, Amar E, El Osta R, Plotton I, Delalande C, Perrin J, Leroy C, Bouker A, Pons H, Lejeune H, Robin G, Boitrelle F.

A case of Inappropriate Antidiuretic Hormone Secretion Syndrome Associated with COVID-19 Pneumonia

Gemcioglu E, Karabuga B, Ercan A, Erden A.

ENDOCRINE EFFECTS OF COVID 19: DIFFICULTIES IN THE MANAGEMENT OF ENDOCRINE DISORDERS FROM INDIVIDUAL TO SOCIETIES

Moroti R, Badiu C.

COVID-19 and Diabetes: Insulin Requirements Parallel Illness Severity in Critically Unwell Patients

Wu L, Girgis CM, Cheung NW.

Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes

Al-Salameh A, Lanoix JP, Bennis Y, Andrejak C, Brochot E, Deschasse G, Dupont H, Goeb V, Jaureguy M, Lion S, Maizel J, Moyet J, Vaysse B, Desailloud R, Ganry O, Schmit JL, Lalau JD.

Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach

Attri B, Goyal A, Gupta Y, Tandon N.

COVID-19 in a Child With Diabetic Ketoacidosis: An Instigator, a Deviator or a Spectator

Daniel S, Gadhiya B, Parikh A, Joshi P.

Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?

Wijaya I, Andhika R, Huang I.

Data-driven modelling and prediction of COVID-19 infection in India and correlation analysis of the virus transmission with socio-economic factors

Kumar A, Rani P, Kumar R, Sharma V, Purohit SR.

Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)

Subir R, Jagat J M, Kalyan K G.

Demographic and Clinical Features of Critically Ill Patients with COVID-19 in Greece: The Burden of Diabetes and Obesity

Halvatsiotis P, Kotanidou A, Tzannis K, Jahaj E, Magira E, Theodorakopoulou M, Konstandopoulou G, Gkeka E, Pouritzaki C, Kapravelos N, Papoti S, Sileli M, Gogos C, Velissaris D, Markou N, Stefanatou E, Vlachogianni G, Aimoniotou E, Komnos A, Zafeiridis T, Koulouvaris P, Armaganidis A, Bamias A, Dimopoulos G.

SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view

Spada F, Pellicori S, Zampino G, Funicelli L, Gervaso L, Laffi A, Rubino M, Garcia-Carbonero R, Fazio N.

Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus

Verma A, Rajput R, Verma S, Balania VKB, Jangra B.

The Effectiveness of Virtual Training on the MiniMed^TM 670G system in people with type 1 diabetes (T1D) during the COVID-19 Pandemic

Vigersky R, Velado K, Zhong A, Agrawal P, Cordero TL.

Diabetes Mellitus Association with Coronavirus Disease 2019 (COVID-19) Severity and Mortality: A Pooled Analysis

Aggarwal G, Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F.

Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic

Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D.

Blood glucose, diabetes and metabolic control in patients with community-acquired pneumonia

Lepper PM, Bals R, Jüni P, von Eynatten M.

Italian recommendations for the diagnosis of gestational diabetes during COVID-19 pandemic: Position statement AMD-SID, diabetes, and pregnancy study group

Torlone E, Festa C, Formoso G, Scavini M, Sculli MA, Succurro E, Sciacca L, Di Bartolo P, Purrello F, Lapolla A.

COVID-19 pandemic and its recovery time of patients in India: A pilot study

Barman MP, Rahman T, Bora K, Borgohain C.

Indian Publications on SARS-CoV-2: A bibliometric study of WHO COVID-19 database

N VR, Patil SB.

Diabetes care during COVID-19 lockdown at a tertiary care centre in India

Joshi R, Atal S, Fatima Z, Balakrishnan S, Sharma S, Joshi A.

Factors Leading to High Morbidity and Mortality of COVID-19 in Patients with Type 2 Diabetes

Rajpal A, Rahimi L, Ismail-Beigi F.

SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes

Obukhov AG, Stevens BR, Prasad R, Calzi SL, Boulton ME, Raizada MK, Oudit GY, Grant MB.

Peri and pos menopausal women in times of coronavirus pandemic

Hipolito Rodrigues M, Carneiro M.

COVID-19 complicated by Hashimoto's thyroiditis

Tee LY, Hajanto S, Rosario BH.

BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank

Sattar N, Ho FK, Gill JM, Ghouri N, Gray SR, Celis-Morales CA, Katikireddi SV, Berry C, Pell JP, McMurray JJ, Welsh P.

Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.)

Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A.

Hypoglycemia at the time of Covid-19 pandemic

Shah K, Tiwaskar M, Chawla P, Kale M, Deshmane R, Sowani A.

Covid-19 and diabesity: when a pandemia cross another pandemia

Guarisco G, Leonetti F.

Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review

Zaki N, Alashwal H, Ibrahim S.

Comment on "Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus"

Wu Y, Xu Y, Meng Z.

A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19

Dou C, Xie X, Peng Z, Tang H, Jiang Z, Zhong Z, Tang J.

Diabetes, Obesity, and Risk Prediction of Severe COVID-19

Muniyappa R, Wilkins KJ.

Gestational diabetes mellitus testing in the COVID-19 pandemic: The problems with simplifying the diagnostic process

van Gemert TE, Moses RG, Pape AV, Morris GJ.

Addressing male sexual and reproductive health in the wake of COVID-19 outbreak

Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Vena W, Jannini EA.

Diabetes and Novel Coronavirus Infection: Implications for Treatment

Williams DM, Nawaz A, Evans M.

Awareness regarding COVID-19 and problems being faced by young adults with type 1 diabetes mellitus amid nationwide lockdown in India: A qualitative interview study

Pal R, Yadav U, Verma A, Bhadada SK.

Data mining and analysis of scientific research data records on Covid-19 mortality, immunity, and vaccine development - In the first wave of the Covid-19 pandemic

Radanliev P, De Roure D, Walton R.

Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review

Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB.

Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: crosstalk among calorie restriction, autophagy and immune response

Hannan MA, Rahman MA, Rahman MS, Al Mamun Sohag A, Dash R, Hossain KS, Farjana M, Uddin MJ.

Caring for Older Adults With Diabetes During the COVID-19 Pandemic

Sy SL, Munshi MN.

Healthcare Workers with Diabetes. Need for more attention in COVID-19 outbreak

Belingheri M, Paladino ME, Labra M, Riva MA.

Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy

Dodesini AR, Galliani S, Ciriello E, Bellante R, Trevisan R.

Diagnostic testing for gestational diabetes mellitus during the COVID-19 pandemic: an opportunity to revisit Glucose-Based testing

Choy KW.

COVID-19 and diabetes: What does the clinician need to know?

Papadokostaki E, Tentolouris N, Liberopoulos E.

Type 1 diabetes onset triggered by COVID-19

Marchand L, Pecquet M, Luyton C.

Understanding The Complex Relationship Between Androgens and SARS-CoV2

Ory J, Lima TFN, Towe M, Frech FS, Best JC, Kava BR, Ramasamy R.

Does androgen deprivation therapy protect against severe complications from COVID-19?

Patel VG, Zhong X, Liaw B, Tremblay D, Tsao CK, Galsky MD, Oh WK.

The Relationship between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China

Shang J, Wang Q, Zhang H, Wang X, Wan J, Yan Y, Gao Y, Cheng J, Li Z, Lin J.

Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report

Ho KS, Narasimhan B, Kumar A, Flynn E, Salonia J, El-Hachem K, Mathew JP.

Balanced diet is a major casualty in COVID-19

Jayawardena R, Misra A.

Fasting blood glucose predicts the occurrence of critical illness in COVID-19 patients: a multicenter retrospective cohort study

Endocrine significance of SARS-CoV-2's reliance on ACE2

Lazartigues E, Qadir MMF, Mauvais-Jarvis F.

Pituitary surgery during Covid-19: a first hand experience and evaluation

Penner F, Grottoli S, Lanotte MMR, Garbossa D, Zenga F.

COVID-19 and metabolic syndrome: could diet be the key?

Demasi M.

Relationship between obesity, diabetes and ICU admission in COVID-19 patients

Fernández García L, Puentes Gutiérrez AB, García Bascones M.

COVID-19 in people living with diabetes: An international consensus

Caballero AE, Ceriello A, Misra A, Aschner P, McDonnell ME, Hassanein M, Ji L, Mbanya JC, Fonseca VA.

SGLT2 inhibition and COVID-19: The road not taken

Das L, Dutta P.

Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study

Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y, Xu J, Wu F, Duan L, Yin Z, Luo H, Xiong N, Xu M, Zeng T, Jin Y.

No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes

Vangoitsenhoven R, Martens PJ, van Nes F, Moyson C, Nobels F, Van Crombrugge P, Wierckx K, van Pottelbergh I, Van Huffel L, Gillard P, Mathieu C.

Unrecognized diabetes in critically ill COVID-19 patients

Klein SJ, Fries D, Kaser S, Mathis S, Thomé C, Joannidis M.

Endocrine and metabolic aspects of the COVID-19 pandemic

Marazuela M, Giustina A, Puig-Domingo M.

Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease

Rastad H, Karim H, Ejtahed HS, Tajbakhsh R, Noorisepehr M, Babaei M, Azimzadeh M, Soleimani A, Inanloo SH, Shafiabadi Hassani N, Rasanezhad F, Shahrestanaki E, Khodaparast Z, Golami H, Qorbani M.

Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences

Lahiri D, Mondal R, Deb S, Bandyopadhyay D, Shome G, Sarkar S, Biswas SC.

COVID-19 and ethnicity: A novel pathophysiological role for inflammation

Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K.

Differential mortality in COVID-19 patients from India and western countries

Jain VK, Iyengar K, Vaish A, Vaishya R.

Vitamin D deficiency in patients with diabetes and COVID- 19 infection

Singh SK, Jain R, Singh S.

Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes

Ushigome E, Yamazaki M, Hamaguchi M, Ito T, Matsubara S, Tsuchido Y, Kasamatsu Y, Nakanishi M, Fujita N, Fukui M.

The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19

Xu Z, Wang Z, Wang S, Ye Y, Luo D, Wan L, Yu A, Sun L, Tesfaye S, Meng Q, Gao L.

Menopausal hormone therapy for women with obesity in the era of COVID-19

Paschou SA, Goulis DG, Lambrinoudaki I, Papanas N.

Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes

Zhang Q, Wei Y, Chen M, Wan Q, Chen X.

Application of Artificial Intelligence in COVID-19 drug repurposing

Mohanty S, Harun Ai Rashid M, Mridul M, Mohanty C, Swayamsiddha S.

Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events

Nandy K, Salunke A, Pathak SK, Pandey A, Doctor C, Puj K, Sharma M, Jain A, Warikoo V.

How do we recover from COVID-19? Helping diabetes teams foresee and prepare for the psychological harms

Stewart R.

Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature

Rahimi L, Malek M, Ismail-Beigi F, Khamseh ME.

The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond

Tramontana F, Napoli N, El-Hajj Fuleihan G, Strollo R.

Hyperglycaemia on admission to hospital and COVID-19

Sardu C, D'Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Paolisso G, Marfella R.

The effect of diabetes on mortality of COVID-19: A protocol for systematic review and meta-analysis

Yang Y, Zhong W, Tian Y, Xie C, Fu X, Zhou H.

Coronaviruses and Integrin αvβ3: Does Thyroid Hormone Modify the Relationship?

Davis PJ, Lin HY, Hercbergs A, Keating KA, Mousa SA.

COVID-19 and diabetes: What have we learned so far?

Taher N, Huda MS, Chowdhury TA.

Admission fasting blood glucose predicts 30-day poor outcome in patients hospitalized for COVID-19 pneumonia

Zhang B, Liu S, Zhang L, Dong Y, Zhang S.

Diabetes, Obesity and COVID-19: A Complex Interplay

Vas P, Hopkins D, Feher MD, Rubino F, Martin MB.

Coronavirus disease (Covid-19): how does the exercise practice in active people with Type 1 Diabetes change? A preliminary survey

Assaloni R, Carnevale Pellino V, Puci MV, Ferraro OE, Lovecchio N, Girelli A, Vandoni M.

Considerations for people with diabetes during the Coronavirus Disease (COVID-19) Pandemic

Sacks LJ, Pham C, Fleming N, Neoh SL, I Ekinci E.

The Impact of COVID-19 on People with Diabetes in Brazil

Thomaz Ugliara Barone M, Bega Harnik S, Vieira de Luca P, Letícia de Souza Lima B, José Pineda Wieselberg R, Ngongo B, Cordeiro Pedrosa H, Pimazoni-Netto A, Reis Franco D, de Fatima Marinho de Souza M, Carvalho Malta D, Giampaoli V.

Reply to comments on Letter to the Editor - Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus

Jie Chee Y, Jia Huey Ng S, Yeoh E.

Diabetes and COVID-19: Global and Regional Perspectives

Jeong IK, Ho Yoon K, Kyu Lee M.

A Novel Indicator Predicts 2019 Novel Coronavirus Infection in Subjects with Diabetes

Ozder A.

COVID-19 Impact on People with Diabetes in the South and Central America

Thomaz Ugliara Barone M, Villarroel D, Vieira de Luca P, Bega Harnik S, Lima B, José Pineda Wieselberg R, Giampaoli V.

Risk Factors for Mortality among COVID-19 Patients

Albitar O, Ballouze R, Ping Ooi J, Maisharah Sheikh Ghadzi S.

School and pre-school children with type 1 diabetes during covid-19 quarantine: the synergic effect of parental care and technology

Schiaffini R, Barbetti F, Rapini N, Inzaghi E, Deodati A, Patera IP, Matteoli MC, Ciampalini P, Carducci C, Lorubbio A, Schiaffini G, Cianfarani S.

Letter to the Editor in response to the article "Lack of type 1 diabetes involvement in the SARS-CoV-2 population: Only a particular coincidence?

Charles Bronson S.

Association of diabetes and hypertension with disease severity in covid-19 patients: a systematic literature review and exploratory meta-analysis

Parveen R, Sehar N, Bajpai R, Bharal Agarwal N.

Sustainable Diabetes Care Services during COVID-19 Pandemic

Alromaihi D, Alamuddin N, George S.

Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: a retrospective study

Li Y, Han X, Alwalid O, Cui Y, Cao Y, Liu J, Gu J, Wang L, Fan Y, Shi H.

Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series

Armeni E, Aziz U, Qamar S, Nasir S, Nethaji C, Negus R, Murch N, Beynon HC, Bouloux P, Rosenthal M, Khan S, Yousseif A, Menon R, Karra E.

Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients

Ma L, Xie W, Li D, Shi L, Ye G, Mao Y, Xiong Y, Sun H, Zheng F, Chen Z, Qin J, Lyu J, Zhang Y, Zhang M.

Diabetes care during the acute phase of infection in ICU patients with specific attention to COVID-19 outbreak

Catargi B, Cheisson G, Tauveron I, Jacqueminet S, Benhamou D.

COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor

Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguère T.

Diabetes and COVID 19 in South-East Asia

Joshi SR, Boulton AJM.

Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators.

Endocrine Surgery during the COVID-19 Pandemic: Recommendations from the Turkish Association of Endocrine Surgery

Aygun N, Iscan Y, Ozdemir M, Soylu S, Aydin OU, Sormaz IC, Dural AC, Sahbaz NA, Teksoz S, Makay O, Emre AU, Haciyanli M, Icoz RG, Giles Y, Isgor A, Uludag M, Tunca F.

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Pranata R, Permana H, Huang I, Lim MA, Soetedjo NNM, Supriyadi R, Soeroto AY, Alkatiri AA, Firman D, Lukito AA.

High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care

Goldman N, Fink D, Cai J, Lee YN, Davies Z.

Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19

El-Missiry MA, El-Missiry ZM, Othman AI.

Coronavirus Disease 2019 and Diabetes: The Epidemic and the Korean Diabetes Association Perspective

Noh J, Chang HH, Jeong IK, Yoon KH.

Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium

Bhaskar S, Rastogi A, Chattu VK, Adisesh A, Thomas P, Alvarado N, Riahi AD, Varun CN, Pai AR, Barsam S, Walker AH.

SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?

Mazucanti CH, Egan JM.

COVID 19: Diabetes and Obesity API-ICP Recommendations

Joshi SR, Tiwaskar MH, Shah SN.

The association between obesity, type 2 diabetes, and hypertension with severe COVID-19 on admission among Mexicans

Denova-Gutiérrez E, Lopez-Gatell H, Alomia-Zegarra JL, López-Ridaura R, Zaragoza-Jimenez CA, Dyer-Leal DD, Cortés-Alcala R, Villa-Reyes T, Gutiérrez-Vargas R, Rodríguez-González K, Escondrillas-Maya C, Barrientos-Gutiérrez T, Rivera JA, Barquera S.

A wave of non-communicable diseases following the COVID-19 pandemic

Lim MA, Huang I, Yonas E, Vania R, Pranata R.

Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective

Singh AK, Majumdar S, Singh R, Misra A.

Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19

Bramante C, Ingraham N, Murray T, Marmor S, Hoversten S, Gronski J, McNeil C, Feng R, Guzman G, Abdelwahab N, King S, Meehan T, Benson B, Pendleton K, Vojta D, Tignanelli CJ.

Mounting clues suggest the coronavirus might trigger diabetes

Mallapaty S.

Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19

Fernandez-Fernandez B, D'Marco L, Górriz JL, Jacobs-Cachá C, Kanbay M, Luis-Lima S, Porrini E, Sarafidis P, Soler MJ, Ortiz A.

Hyperglycemia, Hypertriglyceridemia, and Acute Pancreatitis in COVID-19 Infection: Clinical Implications

Gadiparthi C, Bassi M, Yegneswaran B, Ho S, Pitchumoni CS.

Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals

Chudasama YV, Gillies CL, Zaccardi F, Coles B, Davies MJ, Seidu S, Khunti K.

COVID 19 could trigger global diabetes burden - A hypothesis

Mukherjee S, Banerjee O, Singh S, Maji BK.

Analyzing COVID-19 pandemic for unequal distribution of tests, identified cases, deaths, and fatality rates in the top 18 countries

Shams SA, Haleem A, Javaid M.

Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis

Ghosal S, Arora B, Dutta K, Ghosh A, Sinha B, Misra A.

Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course

Bansal R, Gubbi S, Muniyappa R.

Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring

Fragala MS, Kaufman HW, Meigs JB, Niles JK, McPhaul MJ.

Teledentistry during COVID-19 pandemic

Ghai S.

Clinical Characteristics and Outcome in Patients with Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated with COVID-19: A Retrospective, Hospital-Based Observational Case Series

Hoe Chan K, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim J.

Diabetes and COVID-19: IDF perspective in the Western Pacific Region

Hwang Y, Khasag A, Jia W, Jenkins A, Huang CN, Yabe D, Kim DM, Kadowaki T, Lee MK.

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19

Esam Z.

COVID 19 and low-glucose levels : is there a link ?

Piarulli F, Lapolla A.

Retinal outcomes of COVID-19: possible role of CD147 and cytokine storm in infected patients with diabetes mellitus

Raony Í, Saggioro de Figueiredo C.

COVID-19 and Diabetes from IDF MENA Region

Belkhadir J, Al.

Well-controlled vs Poorly-controlled Diabetes in Patients with COVID-19: Are There Any Differences in Outcomes and Imaging Findings?

Raoufi M, Khalili S, Mansouri M, Mahdavi A, Khalili N.

H(ome)bA1c Testing and Telemedicine: High Satisfaction of People with Diabetes for Diabetes Management During COVID-19 Lockdown

Kanc K, Komel J, Kos M, Wagner J.

Sedentariness and Physical Activity in Type 2 Diabetes mellitus during the COVID-19 Pandemic

Balducci S, Coccia EM.

Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story

Stoian AP, Catrinoiu D, Rizzo M, Ceriello A.

Potential role of incretins in diabetes and COVID-19 infection: a hypothesis worth exploring

Pantanetti P, Cangelosi G, Ambrosio G.

Successful blood glucose management of a severe COVID-19 patient with diabetes: A case report

Hu R, Gao H, Huang D, Jiang D, Chen F, Fu B, Yuan X, Li J, Jiang Z.

Cardiac biomarker-based risk stratification algorithm in patients with severe COVID-19

Mahajan K, Chand Negi P, Ganju N, Asotra S.

COVID-19 and Type 1 Diabetes: Challenges and actions

Klatman EL, Besancon S, Bahendeka S, Mayige M, Ogle GD.

Unexpected high mortality in COVID-19 and diabetic ketoacidosis

Chamorro-Pareja N, Parthasarathy S, Annam J, Hoffman J, Coyle C, Kishore P.

Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19

Smith SM, Boppana A, Traupman JA, Unson E, Maddock DA, Chao K, Dobesh DP, Brufsky A, Connor RI.

Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19)

Zhou Y, Chi J, Lv W, Wang Y.

Serum Amyloid A protein has been undervalued as a biomarker in cases of COVID-19

Gonçalves CA, Sesterheim P.

Adjustments in analyses of vitamin D status, allowing for vitamin D determinants, for Covid-19 risks

Boucher BJ.

Corticosteroids in diabetes patients infected with COVID-19

Deng F, Gao D, Ma X, Guo Y, Wang R, Jiang W, Gong S.

Diabetes management during Ramadan amid Covid-19 pandemic

Tootee A, Esfahani EN, Larijani B.

A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients

Yanai H.

Diagnosis of gestational diabetes during the pandemic: what is the risk of falling through the net?

Ikomi A, Mannan S, Simon G, Khan R, Smith S, Robbins J, Kavanagh U, Crone D.

Letter in response to the article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.)

Santacroce L.

Diabetes, Infection Risk And Covid-19

Erener S.

Challenges of diabetes management during the COVID-19 pandemic

Scott ES, Jenkins AJ, Fulcher GR.

Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic

Kow CS, Hasan SS.

Diabetes increases the mortality of patients with COVID-19: a meta-analysis

Wu ZH, Tang Y, Cheng Q.

People with Diabetes Mellitus: Soft target for COVID-19 infection

Hussain A, Ali I, Hassan Z.

Adrenal Vascular Changes in COVID-19 Autopsies

Iuga AC, Marboe CC, Yilmaz MM, Lefkowitch JH, Gauran C, Lagana SM.

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?

Güemes-Villahoz N, Burgos-Blasco B, Vilela AA, Arriola-Villalobos P, Luna CMR, Sardiña RC, Delgado-Iribarren A, García-Feijoó J.

Why obesity, hypertension, diabetes, and ethnicities are common risk factors for COVID-19 and H1N1 influenza infections

Miyazawa D.

Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing's syndrome

Barbot M, Ceccato F, Scaroni C.

Missing during COVID-19 lockdown: children with onset of type 1 diabetes

Dayal D, Gupta S, Raithatha D, Muralidharan J.

Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India

Ghosh A, Arora B, Gupta R, Anoop S, Misra A.

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

Mantovani A, Byrne CD, Zheng MH, Targher G.

COVID-19, a viral endocrinological disease?

Grassi T, Varotto E, Galassi FM.

Clinical prediction model for mortality of adult diabetes inpatients with COVID-19 in Wuhan, China: A retrospective pilot study

Su M, Yuan J, Peng J, Wu M, Yang Y, Peng YG.

Application of cognitive Internet of Medical Things for COVID-19 pandemic

Swayamsiddha S, Mohanty C.

PERSEVERE OR PERIL: DIABETES CARE IN TIMES OF COVID-19

Barengolts E.

Endourology (Lithiasis). Management, surgical considerations and follow-up of patients in the COVID-19 era

Socarrás MER, Esperto F, Bapstistussi MD, Barufaldi F, Vital MS, Papalia R, Salerno A, Cataldo R, Autrán-Gómez AM, Scarpa RM.

Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?

Cagnacci A, Bonaccorsi G, Gambacciani M; board of the Italian Menopause Society.

Osteoporotic Fractures in the Time of COVID-19

Bhattacharyya T.

Altered Taste in Patients with COVID-19: The Potential Role of Salivary Glands

da Silva Pedrosa M, Sipert CR, Nogueira FN.

The insidious threat of jamu and unregulated traditional medicines in the COVID-19 era

Lim MA, Pranata R.

Letter in response to the article: Vitamin D concentrations and COVID-19 infection in UK biobank (Hastie et al.)

Grant WB, McDonnell SL.

Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method

Maqbool A, Khan NZ.

Letter to Editor in response to "COVID-19: From bench to bedside" by Singh et al

Singh A, Shaikh A, Singh R, Singh AK.

Lifestyle changes in patients with morbid obesity and type 2 diabetes mellitus during the COVID-19 pandemic

Wysocki M, Walƒôdziak M, Proczko-Stepaniak M, Pƒôdziwiatr M, Szeliga J, Major P.

Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality

Stafford EG, Riviere JE, Xu X, Kawakami J, Wyckoff GJ, Jaberi-Douraki M.

Hypermetabolism and COVID-19

Yu PJ, Cassiere H, DeRosa S, Bocchieri K, Yar S, Hartman A.

Dissecting the Interaction between Coronavirus Disease 2019 and Diabetes Mellitus

Chee YJ, Tan SK, Yeoh E.

Possible role of vitamin D in Covid-19 infection in pediatric population

Panfili FM, Roversi M, D'Argenio P, Rossi P, Cappa M, Fintini D.

Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective

Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, Gurnell M, McCormack A, Pineyro MM, Syro LV, Tritos NA, Marcus HJ.

Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank

Raisi-Estabragh Z, McCracken C, Bethell MS, Cooper J, Cooper C, Caulfield MJ, Munroe PB, Harvey NC, Petersen SE.

Diabetic Ketoacidosis in COVID-19: unique concerns and considerations

Palermo NE, Sadhu AR, McDonnell ME.

Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis

Pinto LC, Bertoluci MC.

Severity of COVID-19 and diabetes mellitus: there is still a lot to be learned

Rodacki M.

Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic

Almeida MQ, Mendonca BB.

Endocrinology in the time of COVID-19: Management of neuroendocrine neoplasms (NENs)

Casey RT, Valk GD, Schalin-Jantti C, Grossman AB, Thakker RV.

Update of the hyperglycemia Gestational diagnosis during the COVID-19 pandemic

Codina M, Corcoy R, Goya MM; en representación del GEDE Consenso del Grupo Español de Diabetes y Embarazo (GEDE); GEDE Consenso del Grupo Español de Diabetes y Embarazo (GEDE).

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine

Siniscalchi M, Zingone F, Savarino EV, D'Odorico A, Ciacci C.

Delivery of care remotely through telemedicine in celiac disease: Thinking beyond COVID-19: Commentary on: DLD-20-556R1 "COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine" by Siniscalchi M et al

Ines Pinto-Sanchez M, Lebwohl B.

Is there a link between endocrine disruptors and COVID-19 severe pneumonia?

Ouleghzal H, Rafai M, Elbenaye J.

Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis

Huang Z, Tian D, Liu Y, Lin Z, Lyon CJ, Lai W, Fusco D, Drouin A, Yin X, Hu T, Ning B.

An internet-based algorithm for diabetic foot infection during the COVID-19 pandemic

Liu C, Shi WL, You JX, Li HY, Li L.

Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control?

Deng M, Jiang L, Ren Y, Liao J.

COVID -19 outbreak - Diabetes aspect and perspective

Ahirwar AK, Asia P, Sakarde A, Kaim K.

Multi-Organ Failure in a Patient With Diabetes due to COVID-19 With Clear Lungs

Kabashneh S, Ali H, Alkassis S.

COVID-19: The Endocrine opportunity in a pandemic

Chatterjee S, Ghosh R, Biswas P, Dubey S, Guria RT, Sharma CB, Kalra S.

Religion as a Health Promoter During the 2019/2020 COVID Outbreak: View from Detroit

Modell SM, Kardia SLR.

Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?

Paskins Z, Crawford-Manning F, Bullock L, Jinks C.

Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters

Hartmann-Boyce J, Morris E, Goyder C, Kinton J, Perring J, Nunan D, Mahtani K, Buse JB, Del Prato S, Ji L, Roussel R, Khunti K.

[Impact of the pandemic COVID-19 in andrology. Recommendations in daily clinical practice]

Egui Rojo MA, Fernández-Pascual E, Martínez-Salamanca JI.

Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature

Oriot P, Hermans MP.

Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression

Hatami N, Ahi S, Sadeghinikoo A, Foroughian M, Javdani F, Kalani N, Fereydoni M, Keshavarz P, Hosseini A.

[Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes]

Yang H, Yang LC, Zhang RT, Ling YP, Ge QG.

Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection

Yuksel M, Akturk H, Arikan C.

Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes

Capaldo B, Annuzzi G, Creanza A, Giglio C, De Angelis R, Lupoli R, Masulli M, Riccardi G, Rivellese AA, Bozzetto L.

Diabetes Epidemiology in the COVID-19 Pandemic

Selvin E, Juraschek SP.

Letter to the editor in response to: COVID-19 pandemic and challenges for socio-economic issues, healthcare and national programs in India (Gopalan and Misra)

Pratap Singh R, Kataria R, Ul Haq MF.

Response to the letter of L. Santacroce regarding article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.)

Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P.

Redefining diabetic foot disease management service during COVID-19 pandemic

Jaly I, Iyengar K, Bahl S, Hughes T, Vaishya R.

Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?

Jagat J M, Kalyan K G, Subir R.

Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19

Sharma P, Kumar A.

COVID-19 and addiction

Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S.

Letter to editor in response to "COVID-19: From bench to bedside" by Singh A et al

Singh H, Prasad Dhibar D.

Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies

Costa FF, Ros√°rio WR, Ribeiro Farias AC, de Souza RG, Duarte Gondim RS, Barroso WA.

Projections for COVID-19 pandemic in India and effect of temperature and humidity

Goswami K, Bharali S, Hazarika J.

Letter to the Editor: CoVid-19 and Type 1 Diabetes: every cloud has a silver lining. Searching the reason of a lower aggressiveness of the CoronaVirus disease in Type 1 Diabetes

P Tatti, G Tonolo, Zanfardino A, D Iafusco.

Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection

Heaney AI, Griffin GD, Simon EL.

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic

Galindo RJ, Aleppo G, Klonoff DC, Spanakis EK, Agarwal S, Vellanki P, Olson DE, Umpierrez GE, Davis GM, Pasquel FJ.

COVID-19 IN DIABETES PATIENTS IN UKRAINE: LESSONS FOR DOCTORS AND PATIENTS

Mankovsky B, Halushko O.

Letter to editor in response to article "COVID-19: From bench to bedside" (Singh et al.)

Singh H, Dhibar DP.

Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19

Beran D, Aebischer Perone S, Castellsague Perolini M, Chappuis F, Chopard P, Haller DM, Jacquerioz Bausch F, Maisonneuve H, Perone N, Gastaldi G.

Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them

Iyengar K, Jain VK, Vaishya R.

Is Metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?

Kumar Singh A, Singh R.

Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A Narrative Review

Kumar Singh A, Khunti K.

COVID19 in South Asians/Asian Indians: Heterogeneity of Data and Implications for Pathophysiology and Research

Gupta R, Misra A.

Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19

Wilkinson RJ.

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19

Di Filippo L, Formenti AM, Rovere-Querini P, Carlucci M, Conte C, Ciceri F, Zangrillo A, Giustina A.

Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19

Vigneshwar NG, Krause M, Bartels K.

Saving the Diabetic Foot During the COVID-19 Pandemic: A Tale of Two Cities

Shin L, Bowling FL, Armstrong DG, Boulton AJM.

Diabetic foot ulceration in COVID-19 lockdown: cause for concern or unexpected benefit?

Lipscomb D, Smith AS, Adamson S, Rezazadeh EM.

Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection

Chew KL, Tan SS, Saw S, Pajarillaga A, Zaine S, Khoo C, Wang W, Tambyah P, Jureen R, Sethi SK.

Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in UK: A retrospective single centre study

Alkundi A, Mahmoud I, Musa A, Naveed S, Alshawaf M.

COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess

Pivonello R, Ferrigno R, Isidori AM, Biller BMK, Grossman AB, Colao A.

New-Onset Diabetes in Covid-19

Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, Mingrone G, Boehm B, Cooper ME, Chai Z, Del Prato S, Ji L, Hopkins D, Herman WH, Khunti K, Mbanya JC, Renard E.

Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19

Sardu C, Gargiulo G, Esposito G, Paolisso G, Marfella R.

Psychosocial impact of COVID-19

Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CJ.

Response to 'Vitamin D concentrations and COVID-19 infection in UK Biobank'

Roy AS, Matson M, Herlekar R.

A novel peer-to-peer contact tracking application for COVID-19 and future pandemics

Brown NJ.

Approach to the Patient with Thyrotoxicosis Using Telemedicine

Griffith ML, Bischoff LA, Baum HBA.

Cardiometabolic Risk Factor Control During Times of Crises and Beyond

Brook RD, Levy P, Rajagopalan S.

Worse progression of COVID-19 in men: Is Testosterone a key factor?

Giagulli VA, Guastamacchia E, Magrone T, Jirillo E, Lisco G, De Pergola G, Triggiani V.

Challenges and strategies in management of osteoporosis and fragility fracture care during COVID-19 pandemic

Upadhyaya GK, Iyengar K, Jain VK, Vaishya R.

Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2

Alcocer-Gamba MA, Gutiérrez-Fajardo P, Sosa-Caballero A, Cabrera-Rayo A, Faradji-Hazan RN, Padilla-Padilla FG, Garnica-Cuellar JC, Hernández-Arispe LM, Reyes-Cianeros FA, León-Suárez A, de-Jesús-Rivera J, Mancillas-Adame L, Gaxiola-Macias M, Márquez-Rodríguez E, Miranda-Malpica E, Sanchez-Pedraza V, Lara-Martínez DS, Segovia-Palomo A, Nava-Hernández A, Rivera-Reyes R.

Coronavirus infection in patients with diabetes

Torres-Tamayo M, Caracas-Portillo NA, Peña-Aparicio B, Juárez-Rojas JG, Medina-Urrutia AX, Martínez-Alvarado MDR.

Corrigendum to Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

ACCEPTABILITY AND UTILISATION OF NEWER TECHNOLOGIES AND EFFECTS ON GLYCEMIC CONTROL IN TYPE 2 DIABETES - LESSONS LEARNT FROM LOCKDOWN

Anjana RM, Pradeepa R, Deepa M, Jebarani S, Venkatesan U, Parvathi SJ, Balasubramanyam M, Radha V, Poongothai S, Sudha V, Rani CSS, Harish R, Amutha A, Nagaraj M, Ranjit U, Mohan V.

Managing common endocrine disorders amid COVID-19 pandemic

Pal R, Bhadada SK.

Does glycemic control rescue type 2 diabetic patients from COVID-19-related deaths?

Naruse K.

A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor

Beccuti G, Ghizzoni L, Cambria V, Codullo V, Sacchi P, Lovati E, Mongodi S, Iotti GA, Mojoli F.

What Diabetes Can Teach us About Dealing With COVID-19 and Could it Be a Catalyst for Change in Diabetes?

Stuhr A, Furber S.

Post the Pandemic: How will COVID-19 Transform Diabetic Foot Disease Management?

Najafi B.

The Coronavirus 2019 Pandemic and Diabetes: An International Perspective

Klonoff DC.

Glucovigilance in COVID-19

Lamptey R, Ahomagnon S, Acheampong F, Kalra S.

Endocrine vigilance in COVID-19

Velayoudom FL, Alwis Wijewickrama PS, Ranathunga HI, Somasundaram N.

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view

Berton AM, Prencipe N, Giordano R, Ghigo E, Grottoli S.

Diabetes: Ein Risikofaktor bei COVID-19

Starostzik C.

Endocrine Conditions and COVID-19

Shekhar S, Wurth R, Kamilaris CDC, Eisenhofer G, Barrera FJ, Hajdenberg M, Tonleu J, Hall JE, Schiffrin EL, Porter F, Stratakis CA, Hannah-Shmouni F.

"Does having diabetes increase chances of contracting COVID-19 infection?"

Gangopadhyay KK.

SARS-CoV-2 receptor networks in diabetic kidney disease, BK-Virus nephropathy and COVID-19 associated acute kidney injury

Menon R, Otto EE, Sealfon R, Nair V, Wong AK, Theesfeld CL, Chen X, Wang Y, Boppana A, Kasson PM, Schaub JA, Berthier CC, Eddy S, Lienczewski CC, Godfrey B, Dagenais SL, Sohaney R, Hartman J, Fermin D, Subramanian L, Looker HC, Mariani LH, Naik AS, Nelson RG, Troyanskaya OG, Kretzler M.

Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men

Ghazizadeh Z, Majd H, Richter M, Samuel R, Zekavat SM, Asgharian H, Farahvashi S, Kalantari A, Ramirez J, Zhao H, Natarajan P, Goodarzi H, Fattahi F.

COVID-19 and diabetes mellitus: implications for prognosis and clinical management

Barber TM.

COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging beyond Topics

Saban-Ruiz J, Ly-Pen D.

Endocrinology in the time of COVID-19: Remodelling Diabetes Services and Promoting Innovation

Wake DJ, Gibb FW, Kar P, Kennon B, Klonoff DC, Rayman G, Rutter MK, Sainsbury C, Semple RK.

Thyroid disease in the time of COVID-19

Dworakowska D, Grossman AB.

Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists

Elnaem MH, Cheema E.

Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock

Klonoff DC.

Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy

Pfützner A, Lazzara M, Jantz J.

COVID-19: Impact of and on Diabetes

Schofield J, Leelarathna L, Thabit H.

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

Solerte SB, Di Sabatino A, Galli M, Fiorina P.

Relationship between COVID-19 and obesity

Ekiz T, Pazarlı AC.

COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India

Gopalan HS, Misra A.

A case of subacute thyroiditis associated with Covid-19 infection

Asfuroglu Kalkan E, Ates I.

Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy

Maddaloni E, Coraggio L, Pieralice S, Carlone A, Pozzilli P, Buzzetti R.

Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S

Ebekozien OA, Noor N, Gallagher MP, Alonso GT.

Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study

Wu J, Huang J, Zhu G, Wang Q, Lv Q, Huang Y, Yu Y, Si X, Yi H, Wang C, Liu Y, Xiao H, Zhou Q, Liu X, Yang D, Guan X, Li Y, Peng S, Sung J, Xiao H.

Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings

Goyal A, Gupta S, Gupta Y, Tandon N.

The Australian response to the COVID-19 pandemic and diabetes - lessons learned

Andrikopoulos S, Johnson G.

Recommendations for management of diabetic foot ulcers during COVID-19 outbreak

Kelahmetoglu O, Camlı MF, Kirazoglu A, Erbayat Y, Asgarzade S, Durgun U, Mehdizade T, Yeniocak A, Yildiz K, Sonmez Ergun S, Guneren E.

Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?

Lombardi CP, D'Amore A, Grani G, Ramundo V, Boscherini M, Gordini L, Marzi F, Tedesco S, Bocale R.

An andrologist in the front line Covid-19 team

Baldassarre E.

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia

Ramírez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Mendoza N, Otero B, Sánchez S, Cancelo MJ, Páramo JA, Cano A.

A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic

Korytkowski M, Antinori-Lent K, Drincic A, Hirsch IB, McDonnell ME, Rushakoff R, Muniyappa R.

COVID-19 and applications of smartphone technology in the current pandemic

Iyengar K, Upadhyaya GK, Vaishya R, Jain V.

Management of diabetic persons with foot ulceration during COVID-19 health care emergency: effectiveness of a new triage pathway

Marco M, Valentina I, Laura G, Roberto G, Luigi U.

Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection

Wu J, Zhang J, Sun X, Wang L, Xu Y, Zhang Y, Liu X, Dong C.

Standardized out-patient diagnosis and treatment process for osteoporosis clinics during the COVID-19 pandemic

Zou J, Song DW, Niu JJ, Shi JW, Yang HL.

Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?

Di Stadio A, Della Volpe A, Ralli M, Ricci G.

COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?

Filardi T, Morano S.

A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study

Montastruc JL, Toutain PL.

Covid-19: Pandemic is having "severe" impact on non-communicable disease care, WHO survey finds

Dyer O.

Diabetes and covid-19: more than the sum of two morbidities

Pititto BA, Ferreira SRG.

Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome

Nakajima K.

Managing Type 2 Diabetes Mellitus during COVID-19 Pandemic: The Bittersweet

Yehya A, Carbone S.

Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model

Mongioì LM, Barbagallo F, Condorelli RA, Cannarella R, Aversa A, La Vignera S, Calogero AE.

SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report

Ippolito S, Dentali F, Tanda ML.

Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?

Bellastella G, Maiorino MI, Esposito K.

Partha Kar: Covid-19-time for parity in commissioning diabetes services

Kar P.

COVID-19 Awakens a New Focus on Surge Capacity Blood Glucose Testing and the Critical Role of Telehealth in Self-Management

Fantz CR, Rivers M.

Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals

Shelton C, Demidowich AP, Zilbermint M.

COVID-19: The Underestimated Pandemic Impacting People With Diabetes

Shearer D.

New Paradigms in Diabetes Management From the Epicenter

Levy CJ, Levister CM, Shah NA.

Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?

Koufakis T, Metallidis S, Zebekakis P, Ajjan RA, Kotsa K.

Covid-19 and Diabetes in Hawaii

Melish JS.

Battlefield Endocrinology

Sadhu AR.

Diabetes and severity of COVID-19: What is the link?

Pitocco D, Viti L, Tartaglione L, Di Leo M, Rizzo GE, Manto A, Rizzi A, Caputo S, Pontecorvi A.

Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: a multicentric prospective evaluation

Di Bella S, Cesareo R, De Cristofaro P, Palermo A, Sanson G, Roman-Pognuz E, Zerbato V, Manfrini S, Giacomazzi D, Dal Bo E, Sambataro G, Macchini E, Quintavalle F, Campagna G, Masala R, Ottaviani L, Del Borgo C, Ridola L, Leonetti F, Berlot G, Luzzati R.

COVID-19: Perspectives from people with diabetes

COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil

Teles M, Sacchetta T, Matsumoto Y.

Responding to COVID-19: Agile Use of Information Technology to Serve Patients With Diabetes

Waki K, Sankoda A, Amano S, Ogawa M, Ohe K.

Breastfeeding during the COVID-19 pandemic: suggestions on behalf of Woman Study Group of AMD

Giuliani C, Li Volsi P, Brun E, Chiambretti A, Giandalia A, Tonutti L, Di Bartolo P, Napoli A.

Related molecular mechanisms of COVID-19, hypertension, and diabetes

Akkus E, Sahin M.

A Case of COVID-19 Patient with False-negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese traveller Returning from Wuhan, Hubei Province, China, January 2020

Ishikane M, Miyazato Y, Kustuna S, Suzuki T, Ide S, Nakamura K, Morioka S, Katano H, Suzuki T, Ohmagari N.

Consequences of COVID-19 on people with diabetes

Bellido V, Pérez A.

COVID-19 and Diabetes: Could Diabetes Technology Research Help Pave the Way for Remote Healthcare?

Fuchs J, Hovorka R.

COVID-19: Considerations of Diabetes and Cardiovascular Disease Management

Ceriello A, Schnell O.

Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico

Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, Fermín-Martínez CA, Naveja JJ, Aguilar-Salinas CA.

Monitoring COVID-19 through Trends in Influenza-like Illness and Laboratory-confirmed Influenza and COVID-19 - New York State, excluding New York City, January 1 - April 12, 2020

Rosenberg ES, Hall EW, Rosenthal EM, Maxted AM, Gowie DL, Dufort EM, Blog DS, Hoefer D, St George K, Hutton BJ, Zucker HA; New York State Coronavirus 2019 Response Team.

Challenges of diabetes care management in developing countries with a high incidence of COVID-19: A brief report

Nouhjah S, Jahanfar S.

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Singh AK, Gupta R, Misra A.

Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?

Singh AK, Singh R.

Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Mahajan K, Gaur N.

COVID-19 and diabetes: Is there enough evidence?

Tadic M, Cuspidi C, Sala C.

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators.

Diabetes and COVID-19

Bouhanick B, Cracowski JL, Faillie JL; French Society of Pharmacology, Therapeutics (SFPT).

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike

Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, Xin S, Cao P, Lu J.

Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis

Erol A.

Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19

Li H, Tian S, Chen T, Cui Z, Shi N, Zhong X, Qiu K, Zhang J, Zeng T, Chen L, Zheng J.

The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?

Grandi G, Facchinetti F, Bitzer J.

COVID-19, Type 1 Diabetes Clinical Practice, Research, and Remote Medical Care: A View From the Land Down-Under

Venkatesh N, Paldus B, Lee MH, MacIsaac RJ, Jenkins AJ, O'Neal DN.

Diabetes Care at the Times of Transition and COVID-19 Pandemics (Ukrainian Experience)

Mankovsky B.

Challenges in the Care of Children and Youth With Diabetes in Times of the Corona Pandemic: Personal View of the Situation in a German Clinic

Ziegler R.

Relative Limited Impact of COVID-19 on Diabetes: A Personal View

de Galan BE.

COVID-19 may affect the endocrine pancreas by activating Na(+)/H(+) exchanger 2 and increasing lactate levels

Cure E, Cumhur Cure M.

GP at foot: remote ways to share management of diabetes amid the COVID-19 crisis

Chambers R, Beaney P, Balasubramanian G, Ogunmekan S.

Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits

Martinez-Ferran M, de la Guía-Galipienso F, Sanchis-Gomar F, Pareja-Galeano H.

Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19

Menendez JA.

Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study

Fadini GP, Morieri ML, Longato E, Bonora BM, Pinelli S, Selmin E, Voltan G, Falaguasta D, Tresso S, Costantini G, Sparacino G, Di Camillo B, Tramontan L, Cattelan AM, Vianello A, Fioretto P, Vettor R, Avogaro A.

Why is hyperglycemia worsening COVID-19 and its prognosis?

Ceriello A, De Nigris V, Prattichizzo F.

SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità)

Corona G, Baldi E, Isidori AM, Paoli D, Pallotti F, De Santis L, Francavilla F, La Vignera S, Selice R, Caponecchia L, Pivonello R, Ferlin A, Foresta C, Jannini EA, Lenzi A, Maggi M, Lombardo F.

Would You Believe? A Virus Changes Diabetes Care

Tack CCJ.

The COVID-19 Pandemic Revealed the Importance and Shortcomings of Technologies for Diabetes Support

√Örsand E.

Diabetes and Technology in the Covid-19 Pandemic Crisis

Spanakis EK.

Personal Experiences With COVID-19 and Diabetes Technology: All for Technology Yet Not Technology for All

Monaghan M, Marks B.

Personal Experience With COVID-19 and Community Screening of Diabetic Retinopathy in Iran

Jamali S, Ashrafi E, Mohammadi SF.

Benefits of Technology in the Age of COVID-19 and Diabetes. . .Mobile Phones From a Rwanda Perspective

Krisiunas E, Sibomana L.

Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?"

Pal R, Banerjee M.

COVID-19 and diabetes: The why, the what and the how

Cuschieri S, Grech S.

Some Lessons Learned About Diabetes and COVID-19 During the Early Stage of the Epidemic in Norway

Birkeland KI.

Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis

Mirabelli M, Chiefari E, Puccio L, Foti DP, Brunetti A.

Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility

Chakladar J, Shende N, Li WT, Rajasekaran M, Chang EY, Ongkeko WM.

Endocrinology in the time of COVID-19: Diagnosis and Management of Gestational Diabetes Mellitus

Thangaratinam S, Cooray SD, Sukumar N, Huda MS, Devlieger R, Benhalima K, McAuliffe F, Saravanan P, Teede H.

A new diagnostic strategy for gestational diabetes during the COVID-19 pandemic for the Japanese population

Kasuga Y, Saisho Y, Ikenoue S, Ochiai D, Tanaka M.

In response: Diabetes is a risk factor for the progression and prognosis of COVID-19

Blanke CD.

Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination

Cutolo M, Smith V, Paolino S.

Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?

Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A.

The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19

Whyte MB, Vas P, Heiss C, Feher MD.

The COVID-19 Pandemic: A "Tech"-tonic Shift Toward Virtual Diabetes Care

Ahn DT.

Letter to the Editor: Our Response to Covid-19 as Endocrinologists and Diabetologists

Snyder S.

Endocrine surgery during and after the COVID-19 epidemic: Expert guidelines from AFCE

Baud G, Brunaud L, Lifante JC, Tresallet C, Sebag F, Bizard JP, Mathonnet M, Menegaux F, Caiazzo R, Mirallié E, Pattou F; AFCE COVID Study Group.

Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients

Marfella R, Paolisso P, Sardu C, Bergamaschi L, D'Angelo EC, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Pizzi C, Biffi M, Viale P, Galié N, Paolisso G.

Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports

Scheen AJ, Marre M, Thivolet C.

COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes

Potier L, Julla JB, Roussel R, Boudou P, Gauthier DC, Ketfi C, Gautier JF.

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign"

Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Pascual PF, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A.

SARS-CoV-2 and Diabetes: New Challenges for the Disease

Cristelo C, Azevedo C, Moreira Marques J, Nunes R, Sarmento B.

Characteristics and Outcomes of COVID-19 Positive Patients with Diabetes Managed as Outpatients

Shabto JM, Loerinc L, O'Keefe GA, O'Keefe J.

Metformin, Neutrophils and COVID-19 Infection

Dalan R.

Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study

Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, Chen L, Han D, Fan Y, Zeng Y, Li W, Lin F, Li S, Chen X, Pan P; medical team from Xiangya Hospital to support Hubei, China.

Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

Luo P, Qiu L, Liu Y, Liu XL, Zheng JL, Xue HY, Liu WH, Liu D, Li J.

Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units

Hamdy O, Gabbay RA.

How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future

Castle JR, Rocha L, Ahmann A.

Glucose Monitoring and Diabetes Management in the Time of Coronavirus Disease 2019

Welsh JB, Hu G, Walker TC, Sharma N, Cherñavvsky D.

Time for a Change: Personal Experiences With COVID-19 and Diabetes

Best F.

Personal Experiences With Coronavirus Disease 2019 and Diabetes: The Time for Telemedicine is Now

Mader JK.

TYPE 1 DIABETES TRIGGERED BY COVID-19 PANDEMIC: A POTENTIAL OUTBREAK?

Caruso P, Longo M, Esposito K, Ida Maiorino M.

Type 1 diabetes and technology at time of COVID -19. A case report

Cordera R, Pinducciu C, Maggi D.

Management of Graves' hyperthyroidism and orbitopathy in time of COVID-19 pandemic

Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda ML.

Supporting People With Diabetes, Through COVID-19 and Beyond

Boulton C.

Teleconsultation and Diabetes Care Amid COVID-19 Pandemic in India: Scopes and Challenges

Banerjee M, Chakraborty S, Pal R.

The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins?

Cole SA, Laviada-Molina HA, Serres-Perales JM, Rodriguez-Ayala E, Bastarrachea RA.

Endocrinology in the time of COVID-19: Management of thyroid nodules and cancer

Vrachimis A, Iacovou I, Giannoula E, Giovanella L.

Endocrinology in the time of COVID-19: Management of hyper- and hypo- thyroidism

Boelaert K, Visser WE, Taylor PN, Moran C, Leger J, Persani L.

COVID-19 and diabetes mellitus: A need for prudence in elderly patients from a pooled analysis

Desai R, Singh S, Parekh T, Sachdeva S, Sachdeva R, Kumar G.

Diabetes and metabolic syndrome as risk factors for COVID-19

Marhl M, Grubelnik V, Magdič M, Markovič R.

Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases

Pawar AY, Hiray AP, Sonawane DD, Bhambar RS, Derle DV, Ahire YS.

Significant applications of virtual reality for COVID-19 pandemic

Singh RP, Javaid M, Kataria R, Tyagi M, Haleem A, Suman R.

Obesity as a predictor for a poor prognosis of COVID-19: A systematic review

Tamara A, Tahapary DL.

Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines

Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH.

Subacute thyroiditis after SARS-CoV-2 infection

Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F.

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH.

Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients

Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D, Spreafico F, Greco GF, Cervi G, Pecoriello A, Magini A, Todisco T, Cipriani S, Maseroli E, Corona G, Salonia A, Lenzi A, Maggi M, De Donno G, Vignozzi L.

Diabetes and COVID-19 : Disease-Management-People

Peric S, Stulnig TM.

Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics

D'Marco L, Puchades MJ, Romero-Parra M, Gorriz JL.

Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes on Coronavirus-19 Pandemic

Chen CF, Chen YT, Chen TH, Chen FY, Yang YP, Wang ML, Huo TI, Chang YL, Tan AC, Lin CC.

North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19

Bergsland EK, Halperin DM, Dillon JS, Dasari NA, Kunz PL, Soares HP, Pryma D, Bodei L, Hope T, Soulen MC, Mailman J, Howe JR.

Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits

Rao S, Lau A, So HC.

Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?

Sardu C, D'Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Paolisso G, Marfella R.

Telemedicine Consultations and Diabetes Technology During COVID-19

N√∏rgaard K.

Personal Experience With COVID-19 and Diabetes in the South of France: Technology Facilitates the Management of Diabetes in Disruptive Times

Renard E.

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

Singh AK, Singh A, Singh R, Misra A.

Angiotensin converting enzyme-2 as therapeutic target in COVID-19

Roshanravan N, Ghaffari S, Hedayati M.

The diabetic lung: an easy target for SARS-CoV-2?

Caruso I, Giorgino F.

Diabetes mellitus: Lessons from the COVID-19 pandemic

Tousoulis D.

COVID-19 and diabetes: No time to drag our feet during an untimely pandemic

Kyrou I, Robbins T, Randeva HS.

Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases

De Lorenzo A, Escobar S, Tibiriçá E.

Diabetes and COVID-19

Bouhanick B, Cracowski JL, Faillie JL; French Society of Pharmacology and Therapeutics (SFPT).

[SOLVING ONE OF THE PIECES OF THE PUZZLE: COVID-19 AND TYPE 2 DIABETES]

Pérez-Martínez P, Carrasco Sánchez FJ, Carretero Gómez J, Gómez-Huelgas R.

How diabetes management is adapting amid the COVID-19 pandemic

Ranscombe P.

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic.

Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.

Glycemic control in type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity.

Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E.

Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China

Tao F, Tang X, Tao H, Luo Y, Cao H, Xiang W, Zhao Y, Jin L.

Diabetes during the COVID-19 Pandemic: A Global Call to Reconnect with Patients and Emphasize Lifestyle Changes and Optimise Glycemic and Blood Pressure Control.

Misra A, Bloomgarden Z.

COVID-19 and Gynecomastia: What is the Relationship?

Kazemi MA, Hemmati S, Moradi B, Sharifian H, Firooznia K, Nikravangolsefid N.

New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic.

Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.

Mechanism of inflammatory response in associated comorbidities in COVID-19

de Lucena TMC, da Silva Santos AF, de Lima BR, de Albuquerque Borborema ME, de Azevêdo Silva J.

"Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis."

Singh AK, Singh A, Singh R, Misra A.

Coping with diabetes during the COVID - 19 lockdown in India: Results of an online pilot survey

Nachimuthu S, Vijayalakshmi R, Sudha M, Viswanathan V.

Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic